Overall Incidence of Major Bleeding After Image-Guided Biopsies Low
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Overall Incidence of Major Bleeding After Image-Guided Biopsies Low

RESTON, Va -- February 19, 2010 -- Even among patients who have taken aspirin in proximity to an image-guided percutaneous biopsy, risk of major bleeding associated with the procedure is low, according to a study published in the March issue of the American Journal of Roentgenology.

“With the evolution of imaging guidance, percutaneous biopsy has become a valuable tool in obtaining tissue for diagnosis,” said lead author Thomas D. Atwell, MD, Department of Radiology, Mayo Clinic, Rochester, Minnesota. “Unfortunately, this procedure is not without risk, and haemorrhage is the most feared complication after biopsy.”

The study included a retrospective review of percutaneous biopsies performed at the Mayo Clinic in Rochester over the course of 6 years.

“Among the 15,181 percutaneous biopsies performed during the study period, only 70 haemorrhages (0.5%) were identified within 3 months of biopsy,” said Dr. Atwell. “The incidence of bleeding in patients taking aspirin within 10 days before biopsy was 0.6% (18/3,195).”

“Our study shows that the overall incidence of major bleeding after imaging-guided percutaneous needle biopsy is low, and recent aspirin therapy does not appear to significantly increase the risk of such bleeding complications,” said Dr. Atwell.

“Significant bleeding after percutaneous biopsy is exceptionally rare,” he said. “In most cases, percutaneous biopsy can be performed in patients with recent aspirin use. In those patients undergoing elective, non-urgent deep organ biopsy, scheduling the biopsy 10 days after the last dose of aspirin is a reasonable, but not a necessary, precaution.”

SOURCE: American Roentgen Ray Society

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities